Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf011dc072e5c64d21aa49c134fdc738 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c4322cb4de342be2dbedcbe0c278f6f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 |
filingDate |
2007-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2012-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a9aa45095dd88166e9456d82ec218c2 |
publicationDate |
2012-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8207185-B2 |
titleOfInvention |
CaMKKβ as a target for treating obesity |
abstract |
A method of treating a condition in a subject in need thereof, comprising administering a calcium/calmodulin dependency kinase kinase (CaMKK) inhibitor in a treatment-effective amount. Conditions which may be treated include obesity (particularly adult obesity), insulin resistance (including high fat diet-induced insulin resistance), hyperglycemia (including hyperglycemia accompanying obesity), diabetes, etc. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9879005-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016229846-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10336750-B2 |
priorityDate |
2006-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |